Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05711485 · ClinicalTrials.gov registry record · NA

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

A NA study of Thrombocytopenia and Severe Malaria, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
NA
Development phase
132
Enrollment target
2
Study locations

NCT05711485 is a NA study of Thrombocytopenia and Severe Malaria that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 132 participants, below the 305-participant average among 20 other Thrombocytopenia trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05711485, a NA study of Thrombocytopenia and Severe Malaria, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
NA
Development phase
132 participants
Enrollment target
2
Study locations

Study Summary

Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

Conditions Studied

Thrombocytopenia Severe Malaria

Interventions

  • OTHER Whole blood transfusion

Study Locations (2)

Maryland

  • Johns Hopkins Bloomberg School of Public Health - Baltimore

Copperbelt

  • Tropical Diseases Research Centre - Ndola

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2024-02-24
Est. Completion 2028-05-31
Phase NA

Sponsor

Johns Hopkins Bloomberg School of Public Health

187 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05711485

The ClinicalTrials.gov registry entry for NCT05711485 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 305-participant average among 20 other Thrombocytopenia trials with a reported enrollment target (57% lower). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Thrombocytopenia appearing as the primary indexed condition, and to 1 intervention - of which Whole blood transfusion is the first listed.

NCT05711485 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Copperbelt.

Frequently Asked Questions

What is clinical trial NCT05711485 about?

NCT05711485 is a clinical study titled "Platelet-Directed Whole Blood Transfusion Strategy for Malaria". Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

What is the current status of trial NCT05711485?

This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2024-02-24. Estimated completion is 2028-05-31.

What conditions does trial NCT05711485 study?

This clinical trial studies the following conditions: Thrombocytopenia, Severe Malaria.

What interventions are being tested in trial NCT05711485?

The interventions under investigation include: Whole blood transfusion (OTHER).

Who is sponsoring clinical trial NCT05711485?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05711485 being conducted?

This trial has 2 study locations across Maryland, Copperbelt. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Thrombocytopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Thrombocytopenia

All registered trials for this condition

Severe Malaria

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.